Pasi A. Jänne - Concepedia

Author

Pasi A. Jänne

Also Known As

Beauchamp, Ellen M., Cantley, Lewis C., Espinoza-Delgado, Igor, François Ghiringhelli, Gao, Peng, Janne, Pasi, Jänne, Pasi A., Jӓnne, Pasi A., Li, Danan, Mikse, Oliver

2.3K

Publications

124.6K

Citations

162

H-Index

171

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Brigham and Women's Hospital Massachusetts General Hospital Memorial Sloan Kettering Cancer Center

About

Pasi A. Jänne is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	86	251	38K
2	Health Sciences	28	54	2.8K
3	Natural Sciences	9	9	553
4	Engineering	8	8	2.8K
5	Public Health	6	6	533

Pasi A. Jänne

505

Publications

113.5K

Citations

152

H-Index

Page 1

	Year	Citations
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy J. Guillermo Paez, Pasi A. Jänne, Jeffrey C. Lee, Science	2004	9.4K
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer Eunice L. Kwak, Yung‐Jue Bang, D. Ross Camidge, New England Journal of Medicine	2010	4.5K
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling Jeffrey A. Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi, Science	2007	4.4K
The landscape of somatic copy-number alteration across human cancers Rameen Beroukhim, Craig H. Mermel, Dale Porter, Nature Somatic VariantTumor HeterogeneityMedicinePathologySomatic Copy-number Alteration	2010	4K
<i>EGFR</i> Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram, New England Journal of Medicine	2005	3.9K
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer Alice T. Shaw, Dong‐Wan Kim, Kazuhiko Nakagawa, New England Journal of Medicine	2013	3.4K
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer Pasi A. Jänne, James Chih‐Hsin Yang, Dong‐Wan Kim, New England Journal of Medicine	2015	2.1K
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing Marcin Imieliński, Alice H. Berger, Peter S. Hammerman, Cell Tumor BiologyEngineeringTumor HeterogeneityMedicineNext-generation Sequencing	2012	1.8K
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt, Cancer Discovery	2018	1.5K
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints Shohei Koyama, Esra A. Akbay, Yvonne Y. Li, Nature Communications	2016	1.5K

Page 1